Chronic Calcineurin Inhibitor Nephrotoxicity: Reflections on an Evolving Paradigm

被引:98
作者
Gaston, Robert S. [1 ]
机构
[1] Univ Alabama Birmingham, Div Nephrol, Birmingham, AL 35294 USA
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2009年 / 4卷 / 12期
关键词
RENAL-TRANSPLANT RECIPIENTS; GLOMERULAR-FILTRATION-RATE; MYCOPHENOLATE-MOFETIL; CYCLOSPORINE WITHDRAWAL; ANTILYMPHOCYTE GLOBULIN; KIDNEY-TRANSPLANTATION; ALLOGRAFT RECIPIENTS; PROTOCOL BIOPSIES; FOLLOW-UP; SURVIVAL;
D O I
10.2215/CJN.03820609
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Use of the calcineurin inhibitors (CND cyclosporine and tacrolimus has revolutionized solid organ transplantation. For more than 30 yr, the transplant community has dealt with nephrotoxicity attributed to these agents. Acute renal vasoconstriction (as described by many investigators, including John Curtis and colleagues) is the unequivocal consequence of their use; chronic CNI nephropathy, although indistinct in terms of histology and pathophysiology, has become accepted as a major cause of late kidney allograft failure. This article examines clinical, laboratory, and histologic findings that evolved into a paradigm that was never fully consistent with observed outcomes and new evidence that may offer an alternative interpretation for adverse events that are attributed to CNI nephrotoxicity in kidney transplant recipients. Clin I Am Soc Nephrol 4: 2029-2034, 2009 doi 10 2215/CJN 03820609
引用
收藏
页码:2029 / 2034
页数:6
相关论文
共 55 条
  • [1] Kidney and pancreas transplantation in the United States, 1996-2005
    Andreoni, K. A.
    Brayman, K. L.
    Guidinger, M. K.
    Sommers, C. M.
    Sung, R. S.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (05) : 1359 - 1375
  • [2] Long-term renal effects of low-dose cyclosporine in uveitis-treated patients: Follow-up study
    Bagnis, CI
    Du Montcel, ST
    Beaufils, H
    Jouanneau, C
    Jaudon, MC
    Maksud, P
    Mallet, A
    Lehoang, P
    Deray, G
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (12): : 2962 - 2968
  • [3] CALNE RY, 1978, LANCET, V2, P1323
  • [4] CALNE RY, 1979, LANCET, V2, P1033
  • [5] COMPARISON OF KIDNEY-TRANSPLANT SURVIVAL BETWEEN PATIENTS TREATED WITH CYCLOSPORINE AND THOSE TREATED WITH AZATHIOPRINE AND ANTITHYMOCYTE GLOBULIN
    CHO, SI
    BRADLEY, JW
    MONACO, AP
    TILNEY, NL
    [J]. AMERICAN JOURNAL OF SURGERY, 1984, 147 (04) : 518 - 523
  • [6] Predicting subsequent decline in kidney allograft function from early surveillance biopsies
    Cosio, FG
    Grande, JP
    Wadei, H
    Larson, TS
    Griffin, MD
    Stegall, MD
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (10) : 2464 - 2472
  • [7] CURTIS JJ, 1993, J AM SOC NEPHROL, V3, P1570
  • [8] CURTIS JJ, 1988, AM J MED, V85, P134
  • [9] CYCLOSPORINE IN THERAPEUTIC DOSES INCREASES RENAL-ALLOGRAFT VASCULAR-RESISTANCE
    CURTIS, JJ
    DUBOVSKY, E
    WHELCHEL, JD
    LUKE, RG
    DIETHELM, AG
    JONES, P
    [J]. LANCET, 1986, 2 (8505) : 477 - 479
  • [10] REMISSION OF ESSENTIAL-HYPERTENSION AFTER RENAL-TRANSPLANTATION
    CURTIS, JJ
    LUKE, RG
    DUSTAN, HP
    KASHGARIAN, M
    WHELCHEL, JD
    JONES, P
    DIETHELM, AG
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (17) : 1009 - 1015